Most evidence is based on overexpression studies performed in tumor cell lines, and evidence that ABCC1 chemical inhibition or its genetic deletion increases chemosensitivity in animal models of squamous carcinogenesis is missing. This evidence concerns the gene ABCC1 and neoplasm.